Changes After Suprachoroidal Injection.

Benha University

Status: Unknown

Conditions: Retina; Change; Cataract; Macular Edema; Intraocular Pressure

Treatments: Drug: Suprachoroidal triamcinolone acetonide (SCTA) injection

Study type: Interventional

Funder types: Other

Identifiers

NCT05288192

Rc-3-22

Details and patient eligibility

About

Changes after suprachoroidal injection are analyzed for statistical analysis.

Full description

Changes after suprachoroidal injection of triamcinolone acetonide are noted in various retinal diseases treated by this technique to address its effects over six months of follow-up.

Enrollment: 30 estimated patients

Sex: All

Ages: 30 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients prepared to suprachoroidal injection for various retinal diseases will be enrolled in the study.
• Bilateral retinal diseases that required interventions as diabetic macular edema, exudative retinal detachment, and serous chorioretinopathies.

Exclusion criteria

• Other retinal diseases that are not expected to improve after steroid injections as central retinal artery occlusion and age-related macular degenerations.
• Choroidal neovascularization that require anti-vascular endothelial growth factors.
• Patients refused to have steroid injections even after discussing the nature of their disease with them and the procedure to be done.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

30 participants in 2 patient groups

Suprachoroidal triamcinolone injection

Active Comparator group

Description:

Eyes treated with suprachoroidal injection of triamcinolone acetonide.

Treatment:

Drug: Suprachoroidal triamcinolone acetonide (SCTA) injection

Non-treated eyes

No Intervention group

Description:

Eyes that are receiving no interventions during the study period.